Barclays Maintains Overweight on UnitedHealth Group, Raises Price Target to $604
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Andrew Mok maintains an Overweight rating on UnitedHealth Group (NYSE:UNH) and raises the price target from $560 to $604.
July 17, 2024 | 3:52 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barclays analyst Andrew Mok maintains an Overweight rating on UnitedHealth Group and raises the price target from $560 to $604.
The raised price target and maintained Overweight rating from Barclays is a positive signal for investors, indicating confidence in UnitedHealth Group's future performance. This is likely to result in a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100